Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...

For those who have been prescribed weight loss or diabetes management drugs, like Ozempic, a new warning has been issued.

The World Health Organization has issued its first-ever guidelines for the use of GLP-1 drugs to treat obesity. The WHO has classified obesity as a chronic disease and endorsed the use of these drugs ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

Australia’s top drug regulator has issued a fresh safety warning about the potential risk of suicidal thoughts and ...

Novo Nordisk, Eli Lilly call their diabetes and weight loss drugs “safe and effective” as they face accusations in lawsuits ...

Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...

Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...